Results 121 to 130 of about 1,894 (158)
Some of the next articles are maybe not open access.

Duloxetine hydrochloride

Nature Reviews Drug Discovery, 2004
Anathea B. Waitekus, Peter Kirkpatrick
openaire   +3 more sources

Prurigo successfully treated with duloxetine hydrochloride

Australasian Journal of Dermatology, 2019
AbstractPrurigo is a common skin disease characterised by erythematous macules and papules/nodules with severe pruritus. We report here two cases with treatment‐resistant prurigo that were successfully treated with duloxetine hydrochloride, a serotonin–norepinephrine reuptake inhibitor.
Takashi Hashimoto   +2 more
openaire   +2 more sources

A validated UV spectrophotometric method for determination of duloxetine hydrochloride

Die Pharmazie, 2007
A simple, sensitive and accurate UV spectrophotometric method was developed for the assay of duloxetine hydrochloride in raw material and capsules. Validation of the method yielded good results concerning range, linearity, precision and accuracy. The absorbance was measured at 290 nm for duloxetine capsule solution.
Kamila, M. M., Mondal , N., Ghosh, L. K.
openaire   +2 more sources

Duloxetine Hydrochloride (Cymbalta)

2015
“To live is to suffer, to survive is to find some meaning in the suffering.” Nietzsche’s words ring true to many. Depression is romanticized at times due to its association with poets and artists, but in reality depression, especially major depressive disorder (MDD), can be debilitating. There are two types of depression: MDD and bipolar, also known as
openaire   +1 more source

Case Report: Fulminant Hepatic Failure Involving Duloxetine Hydrochloride

Clinical Gastroenterology and Hepatology, 2006
Duloxetine hydrochloride was approved by the Food and Drug Administration in August 2004 for the treatment of major depressive disorder and diabetic peripheral neuropathic pain. Initial product labeling contained a precaution regarding the risk for increases in liver function test results.
A James, Hanje   +4 more
openaire   +2 more sources

Validation of a stability-indicating HPTLC method for analysis of duloxetine hydrochloride in capsule dosage form. Separation and analysis of duloxetine hydrochloride and olanzapine in a synthetic mixture

Journal of Planar Chromatography – Modern TLC, 2009
A simple, selective, precise, and stability-indicating high-performance thin-layer chromatographic (HPTLC) method has been established and validated for analysis of duloxetine hydrochloride in formulations. The compound was resolved on aluminum-backed silica gel 60 F254 plates with toluene-methanol-10% (v/v) ammonia 3:1.3:0.05 (v/v) as mobile phase ...
Sejal Patel   +5 more
openaire   +1 more source

Treatment of stress urinary incontinence with duloxetine hydrochloride.

Reviews in urology, 2011
Currently, there are no approved medications for the treatment of stress urinary incontinence (SUI) in the United States. The effectiveness of duloxetine in the treatment of SUI is linked to its inhibition of presynaptic neuronal reuptake of serotonin and norepinephrine in the central nervous system, resulting in elevated levels of serotonin and ...
Danielle D, Sweeney   +1 more
openaire   +1 more source

Development and Optimization of Duloxetine Hydrochloride: A Liposomal Drug Delivery System

Drug Delivery Letters
Introduction: Duloxetine Hydrochloride is a selective serotonin and norepinephrine reuptake inhibitor (SSNRI) commonly prescribed for the treatment of depression and anxiety dis-orders. Despite its efficacy, frequent dosing can lead to poor patient compliance and increased side effects.
Ibrahimsha Meeranmydeen   +5 more
openaire   +1 more source

Home - About - Disclaimer - Privacy